Correlation Between Recursion Pharmaceuticals and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Eliem Therapeutics, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Eliem Therapeutics.
Diversification Opportunities for Recursion Pharmaceuticals and Eliem Therapeutics
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Recursion and Eliem is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Eliem Therapeutics
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 0.93 times more return on investment than Eliem Therapeutics. However, Recursion Pharmaceuticals is 1.08 times less risky than Eliem Therapeutics. It trades about -0.13 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 687.00 in Recursion Pharmaceuticals on August 29, 2024 and sell it today you would lose (98.00) from holding Recursion Pharmaceuticals or give up 14.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Eliem Therapeutics
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Eliem Therapeutics |
Recursion Pharmaceuticals and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Eliem Therapeutics
The main advantage of trading using opposite Recursion Pharmaceuticals and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Recursion Pharmaceuticals vs. Bright Minds Biosciences | Recursion Pharmaceuticals vs. HP Inc | Recursion Pharmaceuticals vs. Intel | Recursion Pharmaceuticals vs. Chevron Corp |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |